NK cell defects in X-linked pigmentary reticulate disorder.
Amyloidosis, Familial
/ genetics
Cytotoxicity, Immunologic
DNA Repair
Genetic Diseases, X-Linked
/ genetics
Humans
K562 Cells
Killer Cells, Natural
/ immunology
Minichromosome Maintenance Complex Component 4
/ genetics
Pigmentation Disorders
/ genetics
Recombination, Genetic
Skin Diseases, Genetic
/ genetics
Infectious disease
Inflammation
Innate immunity
Monogenic diseases
NK cells
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
01 11 2019
01 11 2019
Historique:
received:
25
10
2018
accepted:
02
10
2019
entrez:
2
11
2019
pubmed:
2
11
2019
medline:
28
10
2020
Statut:
epublish
Résumé
X-linked reticulate pigmentary disorder (XLPDR, Mendelian Inheritance in Man #301220) is a rare syndrome characterized by recurrent infections and sterile multiorgan inflammation. The syndrome is caused by an intronic mutation in POLA1, the gene encoding the catalytic subunit of DNA polymerase-α (Pol-α), which is responsible for Okazaki fragment synthesis during DNA replication. Reduced POLA1 expression in this condition triggers spontaneous type I interferon expression, which can be linked to the autoinflammatory manifestations of the disease. However, the history of recurrent infections in this syndrome is as yet unexplained. Here we report that patients with XLPDR have reduced NK cell cytotoxic activity and decreased numbers of NK cells, particularly differentiated, stage V, cells (CD3-CD56dim). This phenotype is reminiscent of hypomorphic mutations in MCM4, which encodes a component of the minichromosome maintenance (MCM) helicase complex that is functionally linked to Pol-α during the DNA replication process. We find that POLA1 deficiency leads to MCM4 depletion and that both can impair NK cell natural cytotoxicity and show that this is due to a defect in lytic granule polarization. Altogether, our study provides mechanistic connections between Pol-α and the MCM complex and demonstrates their relevance in NK cell function.
Identifiants
pubmed: 31672938
pii: 125688
doi: 10.1172/jci.insight.125688
pmc: PMC6948767
doi:
pii:
Substances chimiques
MCM4 protein, human
EC 3.6.4.12
Minichromosome Maintenance Complex Component 4
EC 3.6.4.12
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : R01 CA047752
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI120949
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIAID NIH HHS
ID : R56 AI113274
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM065841
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK073639
Pays : United States
Références
Mol Biol Cell. 2010 Jul 1;21(13):2241-56
pubmed: 20444980
Eur J Hum Genet. 2017 May;25(5):646-650
pubmed: 28198391
Nucleic Acids Res. 2002 Jan 1;30(1):207-10
pubmed: 11752295
Radiat Res. 2006 Nov;166(5):693-714
pubmed: 17067213
Br J Dermatol. 2017 Nov;177(5):e200-e201
pubmed: 28407217
Nat Immunol. 2016 May;17(5):495-504
pubmed: 27019227
Am J Med Genet A. 2013 Jun;161A(6):1414-20
pubmed: 23613254
J Clin Invest. 2002 Jun;109(11):1501-9
pubmed: 12045264
Scand J Gastroenterol. 2008;43(4):506-10
pubmed: 18365917
Pediatr Dermatol. 2005 Mar-Apr;22(2):122-6
pubmed: 15804299
Nucleic Acids Res. 2015 Jan;43(Database issue):D82-6
pubmed: 25392420
Pediatr Dermatol. 1993 Dec;10(4):344-51
pubmed: 8302737
J Clin Invest. 2012 Mar;122(3):821-32
pubmed: 22354167
J Clin Invest. 2017 Jan 3;127(1):306-320
pubmed: 27893462
J Clin Invest. 2012 Mar;122(3):814-20
pubmed: 22354170
J Immunol. 2018 Nov 15;201(10):2899-2909
pubmed: 30282752
Nat Genet. 2007 Jan;39(1):93-8
pubmed: 17143284
Nucleic Acids Res. 2017 Jan 4;45(D1):D183-D189
pubmed: 27899595
Methods Mol Biol. 2014;1177:193-209
pubmed: 24943324
J Allergy Clin Immunol. 2013 Sep;132(3):515-525
pubmed: 23993353
Cell. 2017 Jan 12;168(1-2):37-57
pubmed: 28086098
Eur J Dermatol. 2008 Jan-Feb;18(1):102-3
pubmed: 18086616
EBioMedicine. 2016 Apr;6:222-230
pubmed: 27211564
Cell Mol Life Sci. 2005 Aug;62(15):1682-91
pubmed: 15924263
Am J Hum Genet. 2019 May 2;104(5):957-967
pubmed: 31006512
Am J Hum Genet. 2006 Apr;78(4):721-7
pubmed: 16532402
J Clin Invest. 2017 May 1;127(5):1991-2006
pubmed: 28414293
Hum Genet. 2008 Jun;123(5):469-76
pubmed: 18404279
Bioinformatics. 2012 Jul 1;28(13):1805-6
pubmed: 22543366
Blood. 2017 Sep 28;130(13):1553-1564
pubmed: 28778864
J Med Genet. 2012 Apr;49(4):242-5
pubmed: 22499342
Curr Opin Struct Biol. 2018 Dec;53:77-87
pubmed: 30005324
Am J Med Genet. 1981;10(1):65-75
pubmed: 6794369
Adv Immunol. 2014;124:137-70
pubmed: 25175775
Mol Cell Oncol. 2014 Oct 29;1(2):e960754
pubmed: 27308331
J Clin Invest. 2012 Mar;122(3):798-801
pubmed: 22354165
Am J Med Genet. 1989 Jan;32(1):115-9
pubmed: 2705473
Curr Protoc Protein Sci. 2018 Aug;93(1):e62
pubmed: 29927082
Int J Dermatol. 2010 Apr;49(4):421-5
pubmed: 20465698
Annu Rev Immunol. 2013;31:227-58
pubmed: 23516982